Alpha 2.0
Login Register
» Authors » M Cusnir

M Cusnir

Explore the profile of M Cusnir including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 3
Citations 70
Followers 0
Related Specialty
Oncology
Top 10 Co-Authors
D J Cohen
A R Menter
M Rarick
J Berlin
J C Baranda
F Wilhelm
J K Cho
L Fehrenbacher
M Maniar
D L Aisner
Published In
Ann Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer
ONeil B, Scott A, Ma W, Cohen S, Aisner D, Menter A, et al.
Ann Oncol . 2016 Mar; 27(6):1180. PMID: 26945010
No abstract available.
2.
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer
ONeil B, Scott A, Ma W, Cohen S, Leichman L, Aisner D, et al.
Ann Oncol . 2015 Oct; 26(12):2505. PMID: 26489442
No abstract available.
3.
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer
ONeil B, Scott A, Ma W, Cohen S, Aisner D, Menter A, et al.
Ann Oncol . 2015 Jun; 26(9):1923-1929. PMID: 26091808
Background: Rigosertib (ON 01910.Na), a first-in-class Ras mimetic and small-molecule inhibitor of multiple signaling pathways including polo-like kinase 1 (PLK1) and phosphoinositide 3-kinase (PI3K), has shown efficacy in preclinical pancreatic...